Table 3.
Comparison patients with and without heart failure (defined by LVEF Fraction < 52% for male and 54% for female)
| Patients heart failure (n = 18) | Patients without heart failure(n = 107) | p | |
|---|---|---|---|
| Age (Y) | 28 ± 5 | 32 ± 3 | NS |
| BMI (kg/m2) | 11.4 ± 1.6 | 12.3 ± 2.5 | NS |
| FFMI (kg)/weight2) | 10.49 ± 1.0 | 10.18 ± 1.2 | NS |
| FM (%) | 9 ± 2 | 8.8 ± 4 | NS |
| AN types: | |||
| AN-R | 7 (50%) | 84 (76%) | NS |
| AN-BP | 7 (50%) | 27 (24%) | 0.16 |
| Years of evolution of AN since AN diagnosis | 11 ± 5 | 9 ± 7 | NS |
| Selenium (mmol/l) | 1 ± 0.1 | 1.4 ± 0.1 | NS |
| Potassium (mmol/l) | 4 ± 0.6 | 3.8 ± 0,6 | NS |
| Calcium (mmol/l) | 2 ± 0.2 | 2.2 ± 0.1 | NS |
| Magnesium (mmol/l) | 1 ± 0.2 | 0.8 ± 0.1 | NS |
| BNP (pg/l) | 60 ± 63 | 54 ± 63 | NS |
| Albumin (g/l) | 34 ± 9 | 37 ± 7 | NS |
| Transthyretin (mg/l) | 0.218 ± 0.096 | 0.248 ± 0.102 | NS |
| CRP (mg/l) | 5 ± 8 | 7 ± 23 | NS |
| Hypertransaminasemia (% patients) | 71% | 43% | < 0.05 |
| AST (UI) | 290 ± 577.4 | 137.6 ± 425.8 | |
| ALT (UI) | 280 ± 439.7 | 170.1 ± 371.4 | |
| HR (bpm) | 70 ± 25 | 61 ± 17 | NS |
| QT (ms) | 402 ± 59 | 405 ± 54 | NS |
| QTc (ms) | 397 ± 30 | 388 ± 33 | NS |
| QT/QTc | 1.0 ± 0.1 | 1 ± 0.2 | NS |
Data are expressed as mean + SD or number (percentage)
p p-value, NS Not Significant, Y Years, BMI Body Mass Index, FFMI Free Fat Mass Indexed, FM Fat Mass, AN Anorexia Nervosa, AN-R Anorexia Nervosa Restrictive type, AN-BP Anorexia Nervosa Binge Eating/Purging type, BNP Brain Natriuretic Peptide, CRP C-Reactive Protein, AST Aspartate Transaminase, ALT Alanine Transaminase, HR Heart Rate, QTc corrected QT interval